Literature DB >> 35771416

Vasculogenic Mimicry in a 3D Model In Vitro.

Emily Marques Dos Reis1, Fernanda Vieira Berti2, Luismar Marques Porto2.   

Abstract

Increasing studies on vasculogenic mimicry (VM) have shown that the hypoxic microenvironment and the presence of endothelial cell play an important role in regulating tumor phenotype and aggressiveness. Thus, the representation of these factors in vitro becomes necessary to mimic VM. This chapter provides a protocol for mimicking VM in vitro in a more robust 3D model that includes the presence of 3D matrix, melanoma cells, a hypoxia-inducing agent, and endothelial cells.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  3D model; Endothelial cells; Hypoxia; Melanoma cells; Vasculogenic mimicry

Mesh:

Year:  2022        PMID: 35771416     DOI: 10.1007/978-1-0716-2403-6_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

Review 1.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 2.  Modeling tumor microenvironments in vitro.

Authors:  Mingming Wu; Melody A Swartz
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

3.  Bacterial nanocellulose-IKVAV hydrogel matrix modulates melanoma tumor cell adhesion and proliferation and induces vasculogenic mimicry in vitro.

Authors:  Emily M Dos Reis; Fernanda V Berti; Guilherme Colla; Luismar M Porto
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2017-12-05       Impact factor: 3.368

4.  Vasculogenic mimicry and hypoxia-inducible factor-1α expression in cervical squamous cell carcinoma.

Authors:  T J Zhou; X H Huang; L Gong; L Xiang
Journal:  Genet Mol Res       Date:  2016-03-04

5.  Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood.

Authors:  Y S Chang; E di Tomaso; D M McDonald; R Jones; R K Jain; L L Munn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.